狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > huflt3/flk-2-L [huflt3/flk-2-L (#9-2)]
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
huflt3/flk-2-L [huflt3/flk-2-L (#9-2)]
huflt3/flk-2-L [huflt3/flk-2-L (#9-2)]
規格:
貨期:
編號:B200907
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 huflt3/flk-2-L [huflt3/flk-2-L (#9-2)]
商品貨號 B200907
Designations huflt3/flk-2-L [huflt3/flk-2-L (#9-2)]
GenBank Number

U04806

Species Homo sapiens, human
Depositors Immunex Corporation, SL Malaska, Immunex Corporation
Vector
Construct size (kb): 3.990000009536743
Insert
DNA: cDNA
Insert lengths(kb): 0.9879999756813049
Tissue: T-cell cell line clone 22
Gene product: fms-like tyrosine kinase 3 ligand [FLT3LG]
Insert Size (kb) 0.988
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Shipping Information Distributed: freeze-dried
Comments
Restriction digests of the clone give the following sizes (kb): EcoRI--3.0, 1.0; HindIII--4.0.
References

Lyman SD, Beckmann MP. Ligands for flt3 receptors. US Patent 5,554,512 dated Sep 10 1996

Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |